跳至主要内容
临床试验/jRCT2080221836
jRCT2080221836未知2 期

A randomized, double-blind, placebo-controlled, comparative study of HP-3000 in patients with Parkinson's disease not taking L-DOPA

Hisamitsu Pharmaceutical Co.,Inc.0 个研究点开始时间: 待定
适应症

试验速览

阶段
2 期
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
干预模型
Multicenter, randomized, double-blind, parallel group comparison study.

入排标准

年龄范围
20age old over 至 79age old under(—)
性别
All

入选标准

  • Patients diagnosed with Parkinson's disease in stages 1 to 3 on the modified Hoehn & Yahr scale.

排除标准

  • Patients with history of hypersensitivity to ropinirole.
  • Patients with clinically significant renal impairment or hepatic dysfunction.
  • Patients who have cutaneous abnormality at planned application site that can be worsen by application with investigational product.

结局指标

主要结局

-

Efficacy

次要结局

未报告次要终点

研究者

相似试验